title: Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid.
abstract: Though depletion of CSF homovanillic acid (HVA) concentration has often been regarded as a direct indicator of dopamine (DA) deficiency in Parkinson's Disease (PD), CSF HVA is normal in mildly affected patients. To explore why, we measured DA and its metabolites in striatum and CSF in rabbits receiving reserpine for 5 days. Reserpine, which depletes striatal DA by disrupting vesicular storage of the neurotransmitter, results in a compensatory increase of DA turnover. In response to a 96% depletion of striatal DA, its catabolic intermediates 3,4-dihydroxyphenylacetic acid (DOPAC) and 3-methoxytyramine (3-MT) decreased 64% and 92% in striatum, although the endproduct, HVA, was unchanged. In contrast, CSF concentrations of HVA and DOPAC increased significantly, though 3-MT and levodopa (LD) were unaltered. A 5-fold rise in striatal LD concentration after reserpine-induced DA depletion provided evidence for enhanced DA synthesis. As in PD, the compensatory increase of DA synthesis after reserpine administration confounds the ability of CSF HVA to reflect DA depletion.
authors.affiliation: Clinical Neuroscience Center, Sinai Hospital, Wayne State University School of Medicine, Detroit, Michigan, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Loeffler
authors.forename: P A
authors.initials: PA
authors.lastname: LeWitt
authors.forename: A J
authors.initials: AJ
authors.lastname: DeMaggio
authors.forename: P L
authors.initials: PL
authors.lastname: Juneau
authors.forename: P E
authors.initials: PE
authors.lastname: Milbury
authors.forename: W R
authors.initials: WR
authors.lastname: Matson
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000134:cerebrospinal fluid / Q000378:metabolism; D000818:Animals; D015415:Biomarkers; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000096:biosynthesis / Q000134:cerebrospinal fluid / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D007980:Levodopa / Q000134:cerebrospinal fluid / Q000378:metabolism; D008297:Male; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000378:metabolism; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology
chemical_list: D015415:Biomarkers; D015102:3,4-Dihydroxyphenylacetic Acid; D007980:Levodopa; D012110:Reserpine; D004298:Dopamine; D006719:Homovanillic Acid